Correlation Between Lifecore Biomedical and Day One

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lifecore Biomedical and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lifecore Biomedical and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lifecore Biomedical and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Lifecore Biomedical and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lifecore Biomedical with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lifecore Biomedical and Day One.

Diversification Opportunities for Lifecore Biomedical and Day One

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Lifecore and Day is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Lifecore Biomedical and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Lifecore Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lifecore Biomedical are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Lifecore Biomedical i.e., Lifecore Biomedical and Day One go up and down completely randomly.

Pair Corralation between Lifecore Biomedical and Day One

Given the investment horizon of 90 days Lifecore Biomedical is expected to generate 1.97 times more return on investment than Day One. However, Lifecore Biomedical is 1.97 times more volatile than Day One Biopharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest  699.00  in Lifecore Biomedical on October 9, 2024 and sell it today you would lose (12.00) from holding Lifecore Biomedical or give up 1.72% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.8%
ValuesDaily Returns

Lifecore Biomedical  vs.  Day One Biopharmaceuticals

 Performance 
       Timeline  
Lifecore Biomedical 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Lifecore Biomedical are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting fundamental indicators, Lifecore Biomedical reported solid returns over the last few months and may actually be approaching a breakup point.
Day One Biopharmaceu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Lifecore Biomedical and Day One Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lifecore Biomedical and Day One

The main advantage of trading using opposite Lifecore Biomedical and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lifecore Biomedical position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.
The idea behind Lifecore Biomedical and Day One Biopharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum